Pain is an unpleasant physical sensation or emotional experience associated with actual or potential tissue damage. Adverse effects of pain medicines, increase in the prevalence of geriatric population, increase in the prevalence of chronic pain and technological advancements in pain management and surgical devices, are driving the market. According to the National Institute of Health (NIH), the world’s older population continues to grow at an unequal rate. Today, 8.5 percent or 617 million people worldwide are aged 65 and more and this percentage is estimated to increase to 17 percent or 1.6 billion by 2050, According to the American Academy of Pain Medicine, in 2018, more than 1.5 billion people were suffering from chronic pain worldwide. As the patient get older, the incidence and prevalence of pain increases These projections are presenting an immense opportunity for medical devices companies to focus on pain disorders. According to IQ4I analysis, pain management and surgical devices global market is expected to reach $8,824.7 million by 2025.
The pain management and surgical devices market is classified into internal pain devices, external pain devices and pain surgery. The technological advancements in internal pain devices and external pain devices are enhancing the growth of the market. Advancements in internal pain devices include nano-electrodes and wireless technology for spinal cord neurostimulation, point of care ultrasound (POCUS) neuromodulation, miniaturization of devices. Advancements in external pain devices include the convergence of technologies into one device.
Development of new wireless power generator (WPG) is advancement in spinal cord neurostimulator. This technology uses a dipole antenna for the electric field, coupling with microwaves which are very short length pulsed electromagnetic wave at Gigahertz frequency. This device is powered by radioactive electric field attached through tissue at microwave frequencies.
The newly available technology in the field of Neurostimulation is POCUS neuromodulation which integrates the latest advances from the ultrasound imaging, neuromodulation and therapeutic ultrasound for the management of pain. POCUS neuromodulation is used in the treatment of peripheral pain, having origin due to injury, inflammation, neurogenic dysfunction, metabolic dysfunction and musculoskeletal disorders by giving a therapeutic ultrasound to targeted nerve structure that has been identified and localized using ultrasound imaging system.
Companies which are developing pain management internal devices are trending towards miniaturization, because of their easy to use nature, efficacy, and safety factors. Smaller electronic devices generally faster because electric pulses need not travel far within the device. Because of these advantages of small devices, companies are showing interest in the development of smaller devices. For instance, Medtronic developed the world’s smallest implantable device, Intellis implantable neurostimulator.
Key players in internal pain devices market are Abbot Laboratories (U.S.), Boston Scientific (U.S.), Medtronic, Inc. (Ireland), Bioness (U.S.), Mainstay Medical International PLC (Ireland), Nevrocorp (U.S), Nuvectra Corporation (U.S.), SPR Therapeutics (U.S.), Stimwave, LLC. (U.S.), Neuroimpulse (Italy).
The unique technology in the field of external pain devices includes the convergence of different technologies in a single device such as combination of TENS, heat and ultrasound therapy, Ultrasound and laser therapy. Advantages of technological convergence include less expensive, faster effectiveness in pain relief; single device can be used for different application. For instance, Omron Corporation developed the device Heat pain pro the newest device which combines heat and TENS technology in a single device.
Key players in external pain devices market include Biomedical research Ltd (Ireland), Cefaly technologies (U.S.), ElectroCore Medical LLC (U.S.), Electromedical products international, Inc, (U.S.), eNeura, Inc. (U.S.), Iskara medicals d.o.o (Slovenia), Stimwave LLC. (U.S.), Zynex medicals (U.S.), Zetroz systems, LLC. (U.S.), GymnaUniphy NV. (Belgium),
For further information please visit our website: https://www.iq4i.com/reports-category/medicaldevices/r/181 or write to us: firstname.lastname@example.org